Corneal Crosslinking in Keratoconus and Corneal Ectasia

Withdrawn before enrolling · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Progressive Keratoconus, Corneal Ectasia

In brief

Prospective, randomized, single site to determine the safety and effectiveness of performing corneal collagen cross-linking (CXL) using riboflavin and UVA light in eyes progressive keratoconus or corneal ectasia.

Key facts

Study ID

NCT00679666

Run by

Ohio State University

People needed

0

Starts

2008-04-01

Expected to finish

2010-10-01

Last updated by the study team

2017-04-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Diagnosis of keratoconus with documented progression over the previous 12 months.
• Diagnosis of corneal ectasia
• Must be able to complete all study visits.

You may not qualify if…

• Prior corneal surgery in keratoconus group
• Corneal scarring
• Pregnancy

Where it is running

• The Ohio State University Medical Center — Columbus, Ohio, United States
• OSU Havener Eye Institute — Dublin, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.